INVA Q3 2020 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q3 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$89M+34.9% YoY

Gross Profit

$89M100.0% margin

Operating Income

$84M95.2% margin

Net Income

$28M31.8% margin

EPS (Diluted)

$0.26

QoQ Revenue Growth

+12.3%

Cash Flow

Operating Cash Flow

$75M

Free Cash Flow

$75M

Stock-Based Comp.

$441,000

Balance Sheet

Total Assets

$922M

Total Liabilities

$387M

Stockholders' Equity

$486M

Cash & Equivalents

$479M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$89M	$66M	+34.9%
Gross Profit	$89M	$66M	+34.9%
Operating Income	$84M	$61M	+38.9%
Net Income	$28M	$40M	-29.1%